New therapeutic goals in the treatment of dyslipidemia: non-HDL cholesterol and remnant cholesterol. Rev. Fed. Arg. Cardiol. [Internet]. 2024 Mar. 26 [cited 2026 Oct. 5];53(1):5-8. Available from: https://www.revistafac.org.ar/ojs/index.php/revistafac/article/view/564